Physician

Radiation Oncology

Dr. William T. Sause, MD

Dr. William T. Sause works in the field of Radiation Oncology. He went to Medical College of Wisconsin. Medical College of Wisconsin has a rank of 54 in research and a 62 in primary care Doctor William T. Sause, MD is also a published doctor. He has 29 paper published. The most recent paper is: Survival analysis of endometrial cancer patients with cervical stromal involvement. He is registered with Medicare.

Publications

Survival analysis of endometrial cancer patients with cervical stromal involvement.
Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival.
RTOG 0417: Efficacy of Bevacizumab in Combination With Definitive Radiation Therapy and Cisplatin Chemotherapy in Untreated Patients With Locally Advanced Cervical Car...
Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.
Survival Analysis of Endometrial Cancer Patients With Positive Lymph Nodes.
Is short-interval mammography necessary after breast conservation surgery and radiation treatment in breast cancer patients?
Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma: A Radiation Therapy Oncology Group Analysis.
Modeling the Risk of Radiation-Induced Acute Esophagitis for Combined Washington University and RTOG Trial 93-11 Lung Cancer Patients.
Image-Guided Radiotherapy (IGRT) for Prostate Cancer Comparing kV Imaging of Fiducial Markers With Cone Beam Computed Tomography (CBCT).
Higher Biologically Effective Dose of Radiotherapy is Associated with Improved Outcomes for Locally Advanced Non-Small Cell Lung Carcinoma Treated with Chemoradiation:...
Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.
Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10.
Intensity-modulated radiotherapy using implanted fiducial markers with daily portal imaging: assessment of prostate organ motion.
Prostate-specific antigen control with low-dose adjuvant radiotherapy for high-risk prostate cancer.
Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women.
Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10.
Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of ...
Does oncologic specialization influence outcomes following surgery in early stage adenocarcinoma of the endometrium?
Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Onco...
Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factors.
Current treatment recommendations for stage III non-small-cell lung carcinoma.
Induction chemotherapy followed by radical local therapy for locally advanced non-small cell lung cancer.
Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy...
A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 9...
Combined adjuvant radiation and interferon-alpha 2B therapy in high-risk melanoma patients: the potential for increased radiation toxicity.
Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancer.
Outcomes and control rates for I-125 plaque brachytherapy for uveal melanoma: a community-based institutional experience.

Schools

Medical College of Wisconsin
Lds Hospital

Procedures Preformed

Stereotactic Radiosurgery, Spinal

Doctors Specialties

Radiation Oncology
Radiology

Accepted Insurances

Education

University of Florida
Medical College of Wisconsin

Hospital

Intermountain Medical Center

Drug Facts

NPI NUMBER		1881612927
NPPES Provider LastName		SAUSE
NPPES Provider FirstName		WILLIAM
NPPES Provider ZIPCode		841430001
NPPES Provider State		UT
Specialty Description		Radiation Oncology
Total Claim Count		76.0
Distinct Opioid Count		1.0
Opioid Claim Count		24.0
Percent Opioid Claims		31.58

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1881612927
Last Name Of The Provider	SAUSE
First Name Of The Provider	WILLIAM
View All

Similar Doctors

	Dr. Jonathan D. Tward, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. John K. Hayes, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark W. Reilly, MD This Doctor is OpenDoctor Recommended.
	Dr. John W. Thomson, MD This Doctor is OpenDoctor Recommended.
	Dr. Craig M. Carpenter, MD This Doctor is OpenDoctor Recommended.
	Dr. Ada J. Fischbach, MD This Doctor is OpenDoctor Recommended.
	Dr. Charles E. Swallow, MD This Doctor is OpenDoctor Recommended.
	Dr. David K. Gaffney, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Robert J. Lee, MD This Doctor is OpenDoctor Recommended.
	Dr. Jonathan E. Frandsen, MD
	Dr. Breanne E. Terakedis, MD This Doctor is OpenDoctor Recommended.
	Dr. Ying J. Hitchcock, MD This Doctor is OpenDoctor Recommended.
	Dr. David Ly, MD
	Dr. Charles L. Rogers, MD